RE: Minozac moving forward ... G1 Trials
Dr. Cruz says Minozac will be moving forward as well real soon.......if memory serves, Drug Manufacturing was ongoing and Phasel wasn't far off when Neuromedix ran out of funds. Recall they turned down Transitions first offer in the eleventh hour only to fail to raise the cash to move it forward. Transition buys the Company and is still swimming in cash. Another $7,500,00.00 from our Alzheimers Partner Elan was due yesterday from the $200,000,000.00 WorldWide Collaberation Agreement.
..........I would imagine Minozac has been put through the Drug Discovery Engine as well to ensure the best possible Compound is being moved forward. In Dr. Cruz's interview he mentioned a few of the Lead Molecues working their way through the stages.
All in all Transition keeps focused with fulfilling their obligations to the dynamics of the Business Model. Good job Transition Therapeutics!! You're doing exactly what you promised the shareholders.......Exactly.
Neuromedix showed how NOT to get a drug into Clinicals.......whereas Transitions Business Model takes a very large portion of the risk out of the equation by standing fast with their partnership parameters.
Anyone that doesn't like this business model or understand it I would suggest you DO NOT INVEST IN Transition Therapeutics. Too High Risk for most anyways and tends to ring the bell more with the more savvy investor. High Risk-High Reward.........The numbers are astronomical when proper DD is performed. Still if you have no tolerance for Managed Risk with a controlled burn-rate.....STAY AWAY!!! LOL!!
GPP......and cheers all